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Cyclosporine A enhances renin secretion and production in isolated
juxtaglomerular cells. Stimulation of the renin-angiotensin system is a
major side effect of the fungoid immunosuppressant cyclosporine A
(CyA). The aim of this study was to find out whether or not this effect
of CyA results from a direct interaction with renal juxtaglomerular (JG)
cells, which are the site of renal renin synthesis and release. Using
primary cell cultures from rat renal cortex containing more than 80% JG
cells, we found that CyA (0.01 to 10 zg/ml) stimulated renin secretion
threefold. This stimulation was paralleled by a dose-dependent twofold
increase of inactive renin within the cells, while the active intracellular
renin remained the same. In order to identify a possible second
messenger which could mediate the effects of CyA on JG cells, we
examined the simultaneous effects of a single concentration of CyA (I
jsg/ml) on renin secretion, prostaglandin formation and intracellular
cAMP concentration. However, prostaglandin formation and cAMP
were not detectably altered by CyA in experiments where renin
secretion was significantly enhanced. Our results indicate that cyclo-
sporine A stimulates renin secretion and renin synthesis by a direct
effect on renal juxtaglomerular cells. This action of CyA is not mediated
by changes in cellular prostaglandin or intracellular cAMP.
Cyclosporine A (CyA) has become a powerful tooJ in the
management of allograft rejection. However, its usefulness is
limited by side effects, in particular, by nephrotoxicity [1, 21.
Experience has shown that reduced doses of CyA result in
fewer side effects. Nevertheless, development of hypertension
has also been seen under these reduced doses [3]. Recent
attention has been focused on a possible link between CyA and
an elevation of plasma renin activity [4—11]. Thus an increase in
renal renin content [8] and hypertrophy of the juxtaglomerular
apparatus [9] have been observed after CyA administration.
The mode of action by which CyA stimulates the renin-an-
giotensin system (RAS) is not well understood, and in particular
it is not clear whether or not CyA affects the RAS by a direct
effect of renal JG cells or indirectly by its well documented
detrimental effects on renal blood flow [10], glomerular filtration
[1, 12], and tubular function [4].
It was the aim of this study, therefore, to examine the effect
of CyA on isolated renal juxtaglomerular cells and to obtaiii
some indications as to how CyA could alter JG cell function.
For our study we used primary cell cultures from rat renal
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cortex enriched in JG cells (80 to 90%). This cell preparation
has been shown to allow the study of renin secretion on a
cellular level [131. We found that CyA stimulated renin secre-
tion from isolated juxtaglomerular cells in a dose dependent
manner. Moreover, evidence for a dose dependent increase of
intracellular storage of renin was obtained. Both findings to-
gether indicate a stimulation of renin production in isolated JG
cells by CyA.
Methods
Cell culture
Short-term cultures of rat renal juxtaglomerular cells were
made as described previously [14]. Briefly, a single cell suspen-
sion was prepared by kidney perfusion with citrate, enzymatic
dissociation with trypsin and collagenase, and sieving over a 22
sm screen [151. This single cell suspension was further sepa-
rated on a 25% isoosmotic percoll gradient and cells with a
density of 1.06 g/ml were used for culture. For a typical
isolation procedure the kidneys of a single male rat (120 g body
wt) were used. They yielded around 40 million cells which were
mixed with 4 >< 30 ml isoosmotic percoll. From the four
gradients a total of around 3 million cells were harvested from
the bands with a density of 1.06 g/ml. Three x l0 cells were
seeded per 7 cm2 dish. On the second day of culture between 20
and 30% of the seeded cells were attached, and around 90% of
the attached cells contained renin as judged from the specific
immunostaining for rat renin [14]. As a rule, experiments with
the cells were performed two days after seeding. Distribution of
renin containing cells was determined in every third cell prep-
aration with indirect immunofluorescence staining [15].
Renin release
Long term incubation. The culture medium was withdrawn
and replaced by prewarmed fresh culture medium containing
0.5% instead of 2% fetal bovine serum. In different series of
experiments the medium was withdrawn after either 1.5, 4, or
24 hours, centrifuged, and stored at —80° until assay of renin
activity. The cells were scraped off the bottom of the culture
dish in ice cold buffer (0.2 Mmaleate buffer, pH 6.0) plus 5 mM
phenylmethylsulfonylfluoride (PMSF), 10 mM EDTA and 0.1%
gentamycin) sonicated (50 watts for 30 seconds), frozen in
liquid nitrogen, and stored at —80° until assaying renin activity
and protein content.
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Fig. 1. Dependence of renin activity in cells and supernatant on the
trypsin concentration used for activation. Data (mean SEM; N = 5)
are presented as percentage of control (absence of trypsin). Mean
control renin activity was 4.6 ng Al/hr and 10.6 ng Al/hr for cells (•)
and supernatant (s), respectively.
Short term incubations. The culture medium was replaced
with I ml prewarmed, Hepes buffered saline (132 mM NaCI, 5
mM KCI, 0,8 mivi MgSO4, 2 mrvi CaCI2, 10 m Na acetate, 2 mM
NaH2PO4, 10 m glucose, 20 ms'i Hepes, pH 7.2); the culture
dishes were placed on a heating block at 37°C and allowed to
incubate for 10 minutes. Then cyclosporine A (1 cg) was added
to the dishes in a volume of 100 p.l. After different times of
incubation the buffer was removed from the cells, centrifuged,
frozen in liquid nitrogen, and stored at —80°C until assaying
renin activity and PGE2. The dishes were placed on an ice
block. After the addition of 0.4 ml of ice-cold buffer (5 mtvi
potassium phosphate, 0.2 mrt EDTA, 0.5 ms'i 3-isobutyl-methyl-
xanthine and 150 mvi KCI, pH 6.8), the cells were scraped off
with a teflon policeman. The cell suspension so obtained was
sonicated, boiled for five minutes and centrifuged. The super-
natant was frozen in liquid nitrogen and stored at —80°C until
assaying cAMP; the pellet was lysed in I N NaOH and used for
protein determination. In the present study assays were carried
out immediately prior to the addition of cyclosporine and 10, 30
and 60 minutes after the addition.
Activation of inactive renin
Activation of inactive renin was achieved by trypsin treat-
ment. In order to find out the optimal trypsin concentration, the
dependence of renin activity on trypsin concentration was first
examined. As shown in Figure 1, 500 cg/ml trypsin turned out
to be optimal for activation of both the cellular and extracellular
renin; therefore this concentration was used throughout the
activation experiments. Activation of samples was carried out
in the following way: To 10 .cl of cell homogenate or to 100 1.d
medium, 0.1 M phosphate buffer (pH 7.0) was added to a final
volume of 400 ,cl. The activation reaction was started by adding
2 d of a trypsin solution (stock: 100 mg/mI in 0.1 M phosphate
buffer, pH 7.0). After an incubation at 4°C for 60 minutes the
reaction was stopped by the addition of 2 j.cl soybean trypsin
inhibitor (stock: 100 mg/mI in water). After addition of trypsin
inhibitor the reaction vessels were allowed to stand at room
temperature for 15 minutes. The samples thus obtained were
subsequently assayed for renin activity.
Renin activity determination
Renin activity was determined by its ability to generate
angiotensin I from the plasma of bilaterally nephrectomized rats
as described elsewhere [16]. Angiotensin I was measured with a
commercially available radioimmunoassay (Isotopendienst West,
Teufen, Switzerland).
Determination ofPGE2
Concentrations of PGE2 in the buffer were determined by
radioimmunoassay (New England Nuclear, Boston, Massachu-
setts, USA) after appropriate dilution,
Determination of cAMP
The supernatants were assayed for cAMP using a cAMP
binding assay for cAMP exactly as described [17].
Determination of' LDH activity
LDH activities in cellular homogenates or buffers were
assayed with a commercially available kit (Sigma Chemical
Company, St. Louis, Missouri, USA). The samples for LDH
determination were not frozen but subsequently were assayed
after generation.
Determination of' protein
Protein was determined according to the method of Lowry
18] using bovine serum albumin as a standard.
Statistics
Levels of significance were calculated utilizing Student's
unpaired t-test. P < 0.05 was considered significant.
Reagents
All reagents for cell preparation and cell culture were ob-
tained from Boehringer (Mannheim, FRO). Percoll was ob-
tained from Pharmacia (Uppsala, Sweden). Trypsin, TPA and
8-bromo cGMP were purchased from Sigma. CyA and CyH as
pure powders were from the Sandoz Company (Basic, Switzer-
land). As a rule, stock solutions of CyA and CyH were made as
20 mg/mI in pure ethanol. Dilutions were made in water or
buffer. The final concentration of ethanol in all experiments was
less than 0.1%.
Results
The effect of CyA on renin release was assessed by incubat-
ing isolated juxtaglomerular cells for either 1.5, 4 or 24 hours
with different concentrations of CyA (0.01 to 10 cg/m1). The
effect of CyA on renin secretion is shown in Figure 2. It is
obvious from this figure that CyA enhanced renin release at
each time examined in a dose dependent manner. To discover
whether the increase of renin activity by CyA was the result of
an enhanced conversion of inactive to active renin the media
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Fig. 2. Effrct of cyc/osporine A (CyA) on renin re/ease from iso/ated ratjuxtaglomerular ce//s. Cells were incubated for either 1.5 (•), 4 () or
24 (A) hours with CyA. Data are mean SEM of five experiments.
Asterisk indicates P < 0.05 vs. control.
were also subjected to trypsin activation. Trypsin treatment
increased renin activity by 45 9% (mean SEM; N = 15) in
the absence of CyA, and this figure was not significantly altered
by CyA. For instance, renin activities after trypsin activation
after 24 hour incubation were 94 8.4, and 312 69 ng Al/hr
per mg protein (mean sEM; N = 5) in the absence and
presence of 10 rg/ml of CyA, respectively.
To assess a possible damage of the cells by CyA causing an
unspecific passive release of renin from the cells, cellular
morphology, cellular protein, intra- and extracellular lactate
dehydrogenase (LDH) activities and intracellular renin activi-
ties were recorded during the incubation experiments. Cellular
morphology as examined by phase contrast microscopy showed
no obvious alteration in presence of CyA. Furthermore, CyA
did not cause an obvious detachment of cells from the surface of
the culture dishes. This observation was supported by the
results of protein determinations of attached cells after 1.5, 4
and 24 hours of incubation. Cellular protein per 7 cm2 petri dish
ranged from 80 to 145 xg, and this figure was not significantly
altered in presence of CyA.
LDH activity was determined in cells and supernatants after
1.5 and 24 hours of incubation. LDH activity of cells incubated
in absence of CyA was not significantly different between the
two times. Cellular LDH activity was to 4213 303 mU/mg cell
protein (mean SEM; N = 10), and this figure was not
significantly affected by CyA in the concentration range of 0.01
to 10 g/ml. LDH activities in the supernatants were always
below the detection limit (10 mU) of the assay used. Since 200
Cy pg/mI
Fig. 3. Effects ofcyclosporine A and H on 24 hours renin re/ease from
isolated rat juxtag/omeru/ar ce//s. Data (mean SEM; N = 5) are
presented as percentage of control (absence of cyclosporine). Mean
control values were 72 ng Al/hr per mg cellular protein and 24 hours,
and 58 ng Al/hr per mg cellular protein and 24 hours for CyA (•) and
CyH (•), respectively.
pA of supernatant were assayed, the total amount of extracellu-
lar LDH was less than 50 mU per dish. The cellular LDH
activities averaged 450 mU per dish, indicating that extracellu-
lar LDH activity was less than 10% of intracellular activity both
in the absence and presence of CyA.
To gain some information about the specificity of the ob-
served effects of CyA on renin release we also examined the
effect of another cyclosporine, CyH, on the 24-hour renin
release (Fig. 3). It can be seen from Figure 3 that CyH had
almost no effect on renin release from the isolated JG cells.
Intracellular renin activities were determined after 1.5, 4 and
24 hour incubations in the same experiments shown in Figure 2.
In order to measure both active and inactive renin, cellular
renin activity was determined with and without trypsin activa-
tion. For cells incubated for 1.5 hours in the absence of CyA,
renin activity was 1122 84 ng Al/hr per mg of protein (mean
sEM; N = 5) without trypsin activation, and 2356 302 ng
AI/h-4 per mg protein with trypsin activation. For the series of
experiments in which the cells were incubated for four hours
the respective values were 1458 76 and 3645 160. Neither
afer 1.5 nor after 4 hours of incubation were cellular renin
activities with and without trypsin activation significantly al-
tered by CyA. After 24 hours of incubation, however, CyA
caused a concentration dependent increase in trypsin activat-
able renin, while initially active renin was not altered by CyA
(Fig. 4),
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Table 1. Effect of 12-O-tetradecanoylphorbol 13-acetate (TPA) and
8-bromo cyclic GMP on 24-hr renin release from isolated rat juxtaglo-
merular cells in the absence and the presence of CyA (10 p.glml)
Renin activity released
ng Al/hr per mg
cellular protein and 24 hrs
without CyA with CyA
TPA 0 45.4 6.2 94.4 8.3
TPA 100 nM 31.8 2.8k' 45.4 10.6"
8-bromo cGMP 0 32.6 3.6 72.0 5.3
8-bromo cGMP 10 .rM 20.8 2.4" 43.5 3.1
not renin release evoked by CyA could be inhibited by manip-
ulations that usually inhibit renin release from isolated JO cells.
There is evidence that addition of phorbol esters and an
increase of intracellular cGMP inhibits renin release [131. We
therefore examined the effects of the phorbol ester 12-0-tetra-
decanoylphorbol 13-acetate (TPA, 100 nM) and the cyclic GMP
derivative 8-brorno cOMP (10 /LM) on 24-hour renin release in
the absence and presence of CyA (10 .rg/ml). The results of
these experiments are documented in Table 1. It is apparent
that both the basal and CyA stimulated renin release were
attenuated by TPA and 8-bromo cGMP.
The sum of the results obtained from the experiments de-
scribed above suggests that CyA enhances renin release from
isolated juxtaglomerular cells by a specific effect rather than by
causing cell damage. The next series of experiments was
therefore done to gain some insight into the intracellular mech-
anism by which CyA stimulates renin secretion.
First, we determined the lag time required for CyA to
stimulate renin secretion. Isolated juxtaglomerular cells were
incubated with or without a single concentration of CyA (I
g/ml) and the amount of renin released after 10, 30 and 60
minutes was determined (Fig. 5A). The amount of renin re-
leased was significantly higher in presence of CyA after only 10
minutes, indicating a fast onset of action for CyA on juxtaglo-
merular cells.
It has been reported that CyA is capable of enhancing
prostaglandin release from tissues [19—21]. Since prostaglan-
dins, in particular PGE2, are stimulators ofrenin secretion [221,
we measured the rate of POE, release and renin secretion in the
same experiments (Fig. 5B). It is obvious in this figure that CyA
(1 g/ml) did not alter POE2 release.
Another second messenger that has been established as a
stimulatory signal for renin secretion is cAMP [23]. Therefore,
in some experiments we measured the intracellular cAMP
levels in addition to renin secretion and PGE2 release (Fig. SC).
It can be seen in this figure that CyA (1 pg/mI) did not affect
intracellular cAMP levels.
A final set of experiments was done to examine whether or
Discussion
Under cyclosporine A (CyA) treatment an increase of plasma
renin activity (PRA) has often been observed in humans and in
laboratory animals [4], in particular, during acute administra-
lion of the drug. Since PRA is primarily determined by the rate
of renin secretion from the kidneys, the question arises as to
how CyA stimulates renal renin release. CyA has been found to
cause a variety of changes in renal function including a decrease
of renal blood flow [10], a decrease of glomerular filtration [I,
12] and tubular damage [41. Renin secretion on the other hand is
known to be dependent on the renal perfusion pressure, on
glomerular filtration, and in particular, on the load of sodium
chloride in the region of the macula densa [22]. At the moment
it is now known whether the enhancement of renin secretion is
a consequence of the alterations of renal functional parameters
by CyA or is due to a direct effect of CyA on juxtaglomerular
cells, which are the site of renal renin production and secretion.
Our experiments as documented in Figure I clearly show that
CyA is capable of stimulating renin release from isolated
juxtaglomerular cells in a dose dependent fashion. The increase
of extracellular renin activity was not due to an increased
conversion of prorenin to renin, because the proportion of
active to inactive renin was not affected by CyA. Since CyA did
not alter apparent cellular morphology and cellular protein
content, nor did it cause the release of unspecific cytosolic
proteins such as LDH, we may infer that CyA stimulates renin
release from isolated juxtaglomerular cells by a specific effect
rather than by causing cell damage. Experiments with CyH
provide a further indication that this effect of CyA is a specific
cyclosporine effect. CyH differs from CyA only at amino acid
position 11, and only weakly binds to cyclosphilin. CyH is
orders of magnitude less effective in immunosuppression than
CyA, and the same holds for adverse renal side effects (Dr.
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Fig. 4. Effect of cyclosporine A (CyA) on actice (C)) and tiypsmn
activatable (•) renin within isolated rat juxtaglomerular cells after 24
hours of incubation with CyA. Data are mean SEM of five experi-
ments. Asterisk indicates P < 0.05 vs. control.
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Ryffel, personal communication). Thus the observation that
CyH did not enhance renin secretion argues against an unspe-
cific cyclosporine effect on the one hand and fits well with the in
vivo observations on the other. Concerning the direct effect of
CyA on renin secretion, our results are in harmony with the
more single finding obtained by Baxter et al [24] ihat CyA in a
concentration of 8 rM stimulates renin release from renal
cortical slices in a time interval between 30 to 240 minutes.
We obtained evidence that CyA led to an increase of trypsin
activatable renin activity within the cells in a dose dependent
fashion in an incubation interval between 4 and 24 hours (Fig.
4). Since trypsin activatable renin is considered prorenin [25],
our results as documented in Figure 4 indicate that CyA
increased the amount of intracellular prorenin without changing
the amount of primarily active renin.
Together with the observation that extracellular renin was
also increased by CyA, these findings suggest that CyA not only
stimulates renin secretion but also renin production in isolated
juxtaglomerular cells, at least after 24 hours.
This conclusion fits well with the observations that CyA in
vivo not only increases PRA but also renal renin content [81.
Taken together we infer from our results that CyA is capable of
stimulating renin secretion and renin production in isolated
juxtaglomerular cells by a direct effect in these cells.
We tried to gain some insight as to how CyA could affect
juxtaglomerular cell function. The intracellular mediation of the
effects of CyA on target cells is generally not well understood.
There is evidence for a cytosolic binding protein for CyA named
cyclosphilin [26]. The dissociation constant for CyA to cyclo-
sphilin is 2 x 1O M. Interestingly this value is very close to the
concentrations for CyA required for half maximal effects on
renin secretion and intracellular accumulation of prorenin,
which we estimated to be around IO M from the data pre-
sented in Figures 2 and 4. Thus a mediation of the effects of
CyA on juxtaglomerular cells by binding to cyclosphilin is
consistent with these data.
Our results as documented in Figure 5A indicate that the
effect of CyA on renin secretion begins within the first ten
minutes, suggesting a rapid onset of action on juxtaglomerular
cells. An almost immediate onset of action of CyA was also
observed by Nicchita, Kamoun and Williamson [27] who stud-
ied the influence of CyA on calcium handling in isolated
hepatocytes.
There are some reports in the literature that CyA is capable of
enhancing renal PGE2 release [19—21]. Since PGE2 is a stimu-
lator of renin secretion [22] we examined whether or not
enhancement of renin secretion by CyA could be due to an
enhancement of PGE2 formation in the isolated cells. However,
as shown in Figure SB we failed to detect a stimulation of PGE2
release by CyA in the same experiments in which renin secre-
tion was stimulated (Fig. 5A). This in vitro finding parallels the
in vivo results of Baxter et al [281 who observed a stimulation of
renin secretion without an enhancement of renal prostaglandin
release by CyA. Thus we may infer that stimulation of renin
secretion from juxtaglomerular cells by CyA is not due to an
enhanced prostaglandin synthesis.
The best characterized, stimulatory intracellular signal for
renin secretion in juxtaglomerular cells is cAMP [23]. It was
therefore obviously important to examine the influence of CyA
on intracellular cAMP levels in isolated juxtaglomerular cells.
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Fig. 5. A Time course of extracellular renin activity (ng A I/hr per mg of
prot.) after addition of cyclosporine (CyA) 0 (0) or I .sg/ml (•) to
isolated rat renal juxtaglomerular cells. Data are mean SCM of five
experiments. Asterisk indicates P < 0.05 vs. control. B Time course of
extracellular prostaglandin E2 (PGE2) (ng PGE2Iper mg of protein) after
addition of CyA 0 (0) or 1 g/ml (•) to isolated rat renal juxtaglomer-
ular cells. Data are mean SEM of five experiments. C Time course of
intracellular cAMP levels (pmol cAMP/mg prot.) after addition of CyA
0(0) or I .tg/ml (S) to isolated rat renal juxtaglomerular cells. Data are
mean SCM of five experiments.
As documented in Figure SC, CyA (1 g/ml) did not affect
intracellular cAMP in the same experimental conditions under
which a stimulation of renin secretion was observed. Thus we
may infer that cAMP is not likely to be the second messenger
mediating the effect of CyA on juxtaglomerular cells. Also
Duggin et al [29] did not observe a stimulation of cAMP release
from renal tissues by CyA.
Recently it has been shown that CyA also binds to calmodulin
[301. In this context it has been demonstrated that CyA inhibits
calmodulin dependent reactions. Moreover, binding of CyA to
calmodulin was found to be competitively inhibited by calmod-
ulin antagonists. Since calmodulin antagonists are well docu-
mented stimulators of renin secretion [23], calmodulin antago-
nism could be a possible explanation for the stimulatory effect
of CyA on renin secretion. Half maximal inhibition of calmod-
ulin mediated reactions were observed at around 100 nM CyA
[30].
As already mentioned above, this is the same concentration
of CyA at which half maximal effects on renin secretion and on
intracellular renin content were observed.
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Although our results do not permit us to infer a mechanism by
which CyA enhances renin secretion, some findings indicate
that the mechanism of renin secretion is not totally different in
presence of CyA. This conclusion is made from the observation
that phorbol ester and cyclic GMP inhibit renin secretion in the
absence and the presence of CyA (Table I).
In summary, the results obtained in this study suggest that
CyA has a direct effect on rat renal juxtaglomerular cells. It
enhances renin secretion from these cells with a fast onset of
action. With some delay it also leads to an increase in the
intracellular amount of prorenin. Since CyA causes both an
enhanced release of renin and, simultaneously an increase in
renin stores, we may infer that CyA also stimulates renin
production. The mode of action by which CyA could affect
juxtaglomerular cell function is less clear. From our experi-
ments neither prostaglandins nor cAMP appear to be mediators.
If CyA acts as a calmodulin antagonist in juxtaglomerular cells,
as it has been demonstrated so far only for T-lymphocytes [30],
then a calmodulin antagonism would be a likely explanation for
the effects of CyA on juxtaglomerular cells.
From a more clinical point of view it is of importance that the
effects of CyA on isolated juxtaglomerular cells occurred at
concentrations that are typical extracel lular concentrations
during CyA treatment [41. Thus a direct effect of CyA on
juxtaglomerular cells in vivo is not unlikely. In vivo CyA causes
an increase of plasma renin activity during acute or short term
administration. Long-term administration has been reported to
lower plasma renin activity and to depress the RAS. The cell
culture system of JG cells only permits short-term studies [15].
Our results can therefore only be compared with the situation of
acute administration of CyA in vivo, and these results could
help to understand how CyA elevates plasma renin activity.
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